The binding of MM cells to fibronectin upregulates p27 and induces nuclear factor κB (NFκB) activation in MM cells [6], which confer cell adhesion-mediated drug resistance (CAM-DR) to conventional chemotherapy [9]. Here, NFKB1 is linked to Miyoshi myopathy.